Evert S.M. van Aken

Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy

Maria I. van Rijn–Dekker, L. Van den Bosch, Johanna G.M. van den Hoek et al. · Radiotherapy and Oncology · 2020 · 131 citations · Full text

Medicine, Oncology, Radiation Oncology +6

Risk of ischaemic cerebrovascular events in head and neck cancer patients is associated with carotid artery radiation dose

Evert S.M. van Aken, Hans Paul van der Laan, Hendrik P. Bijl et al. · Radiotherapy and Oncology · 2021 · 37 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Unexpected toxicity of <scp>CDK4</scp>/6 inhibitor palbociclib and radiotherapy

Evert S.M. van Aken, Aart Beeker, Ilse Houtenbos et al. · Cancer Reports · 2021 · 13 citations · Full text

Medicine, Oncology, Pharmacology +17

ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors

Evert S.M. van Aken, Bharti Devnani, Arsela Prelaj et al. · Annals of Oncology · 2025 · 11 citations · Full text

Medicine, Oncology, Radiation Oncology +17